Metaboost Rx review

The microdose page here is the most substantive clinical writing here — the mechanism staged properly, explicit candidate and exclusion lists, a month-by-month timeline, and an honest statement that microdosing is the wrong choice for someone with significant weight to lose. Then it declines to price it, while a figure for it sits unrendered in the site's own JavaScript. Alongside that, three mutually inconsistent price sets ship simultaneously: the hero, the cards and the shipped data each say something different, and the hero figure matches no product at any tier.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1300/mo is the full published spread in our ranking

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Metaboost Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Metaboost Rx is a physician-directed telehealth weight-loss practice based in Oklahoma City and serving patients nationwide, selling compounded semaglutide, compounded tirzepatide, a GLP-1 microdose protocol and adjunct peptide therapy. Intake is a fully online HIPAA-compliant assessment, followed by licensed clinical review, cold-chain delivery and continuous secure messaging; the site advertises no charge if you are not approved and takes no insurance. Medication is described as prepared by partner compounding pharmacies and shipped on a structured cadence, with no pharmacy named and no 503A/503B classification given. It positions the microdose protocol as its differentiator, aimed at body composition rather than weight loss.

Three mutually inconsistent price sets ship at the same time: the hero advertises one figure, the pricing cards a second, and the site's own shipped data a third. The same drug carries two different prices depending on where on the page you look, and the hero figure matches no product at any tier

• The GLP-1 Microdose — the program the site itself calls the reason many members come to it — carries no price on its own page, only "available by consultation", while the number exists in the bundle
• Production HTML ships social-preview images pointing at a localhost development address, which breaks every social share
• The site's own analytics configuration is disabled in production for want of a configuration value
• The sitemap returns an error page, and no pharmacy, legal entity or 503A/503B classification is disclosed anywhere
• No milligram figure is published for any program, including the microdose whose entire premise is a lower dose
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Metaboost Rx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Who should not microdose
• What microdosing GLP-1 costs
• The true annual cost of a plan
• What a flat price costs at a low dose